Eli Lilly says its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep-related disorder in two late-stage trials, paving the way for expanding use of the drug. The drug cut the frequency of irregular breathing episodes by as much as… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, […]
Published on April 18, 2024
Most doses of Eli Lilly’s diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand, the U.S. Food and Drug Administration’s website showed on Wednesday. Both drugs had limited availability… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]
Published on April 18, 2024
Active women using the pill appear to receive an added bonus from their birth control, a new study says. These women are less likely to suffer sprains and strains than women not on birth control, researchers reported recently in the journal Medicine & Science in Sports &… Read Full Article (External Site) Dr. David LowemannDr. […]
Published on April 18, 2024